Free Trial
LON:SHRS

Shires Income (SHRS) Share Price, News & Analysis

GBX 234 0.00 (0.00%)
(As of 09:53 AM ET)

About Shires Income Stock (LON:SHRS)

Key Stats

Today's Range
232
234
50-Day Range
231
247.50
52-Week Range
207.95
253
Volume
49,653 shs
Average Volume
70,220 shs
Market Capitalization
£96.80 million
P/E Ratio
N/A
Dividend Yield
5.98%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Shires Income PLC is a closed ended equity mutual fund launched and managed by Aberdeen Fund Managers Limited. The fund is co-managed by Aberdeen Asset Managers Limited. It invests in the public equity markets of the United Kingdom. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in ordinary, convertible, and preference shares of companies. The fund employs fundamental analysis with a bottom-up stock picking approach with a focus on factors like management, business focus, balance sheet, corporate governance, financial ratios, market, peer group, and business prospects to create its portfolio. It benchmarks the performance of its portfolio against the FTSE All-Share Index (Total Return). Shires Income PLC was formed in 1929 and is domiciled in the United Kingdom.

Receive SHRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shires Income and its competitors with MarketBeat's FREE daily newsletter.

SHRS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

SHRS Stock Analysis - Frequently Asked Questions

Shires Income's stock was trading at GBX 226 at the beginning of the year. Since then, SHRS shares have increased by 3.5% and is now trading at GBX 233.99.
View the best growth stocks for 2024 here
.

Shares of SHRS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Shires Income investors own include Galectin Therapeutics (GALT) and Esperion Therapeutics (ESPR).

Company Calendar

Ex-Dividend for 10/31 Dividend
10/03/2024
Dividend Payable
10/31/2024
Today
11/21/2024

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
£-1,470,000.00
Net Margins
-216.15%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£10.57 million
Cash Flow
GBX 4.34 per share
Book Value
GBX 256 per share

Miscellaneous

Free Float
N/A
Market Cap
£96.81 million
Optionable
Not Optionable
Beta
0.86
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:SHRS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners